Back to News
investment

Why Teradyne Stock Soared Last Month

newsfeedback@fool.com (Eric Volkman)
Loading...
4 min read
0 likes
⚡ Quantum Brief
The robotics and semiconductor diagnostics company surged 33% in February 2026 after reporting Q4 2025 earnings that crushed analyst expectations, driven by AI-driven chip demand. Revenue soared 44% year-over-year to $1.08 billion, led by semiconductor diagnostics ($883M), while non-GAAP net income jumped 83% to $283M ($1.80/share), far exceeding forecasts. Management forecasted Q1 2026 revenue of $1.15B–$1.25B and EPS of $1.89–$2.25, again surpassing consensus estimates ($942M revenue, $1.25 EPS). Analysts responded by raising price targets, with Morgan Stanley’s Shane Brett increasing his twice in a week (to $306/share) while maintaining a neutral rating. The rally reflects Teradyne’s critical role in AI chip testing, with sustained demand expected to fuel long-term growth despite valuation concerns.
AI Audio Summary
0:00 / 0:00
Click to play
97f3403c-cafd-4120-938d-c54e631f918d.jpeg
Quantum News · Media Library

By Eric Volkman – Mar 8, 2026 at 7:41PM ESTKey PointsAI was helping power the company's fundamentals, a trend that was abundantly clear towards the end of 2025.A clutch of analysts raised their price targets on its shares too.Highly specialized robotics company Teradyne (TER 10.51%) was a popular stock on the market in February. A rally kicked off following the company's latest earnings report on Feb. 2, with the estimates-trouncing period setting the tone for the stock across the rest of the month. From the first trading day to the last in February, Teradyne's shares gained almost 33%. Advancing with AI Teradyne's fourth quarter of 2025 was outstanding in many respects, not least because the robtotics company grew both revenue and profitability at impressive rates. Image source: Getty Images. The former metric surged 44% year over year to $1.08 billion. Not surprisingly, the company's semiconductor diagnostics products accounted for the leading revenue source, bringing in $883 million. Its other two product categories (product and robotics testing) contributed $110 million and $89 million, respectively. All three posted top-line gains over the previous quarter, the company said. The semiconductor segment is hot right now due to consistently heavy demand for artificial intelligence (AI). Chips that can handle AI workflows require vigorous testing, which plays beautifully into the hands of a diagnostics specialist like Teradyne. The company's bottom line also improved dramatically, with net income not in accordance with generally accepted accounting principles (GAAP) rocketing almost 83% higher to $283 million, or $1.80 per share. Those two headline figures were miles above the consensus analyst estimates. Collectively, pundits tracking Teradyne stock were modeling revenue of just over $969 million, and non-GAAP (adjusted) net income of only $1.36 per share. Management expects the growth train to keep thundering down the tracks. For its current (first) quarter, the company expects revenue of $1.15 billion to $1.25 billion and adjusted net earnings per share (EPS) of $1.89 to $2.25. Again, both are substantially above the consensus prognosticator forecasts: $942 million for the former line item and $1.25 per share for the latter. ExpandNASDAQ: TERTeradyneToday's Change(-10.51%) $-32.13Current Price$273.45Key Data PointsMarket Cap$43BDay's Range$269.15 - $294.9452wk Range$65.77 - $344.92Volume215KAvg Vol3.3MGross Margin57.94%Dividend Yield0.18% The race to raise As often happens when a company posts a blowout quarter, analysts tracking Teradyne became notably more bullish on its stock, with more than a few raising their price targets. One of those pundits wasn't content with just a single raise. Morgan Stanley's Shane Brett upped his price target to $288 per share from his previous $229 just after earnings were published, although he maintained his equalweight (read: hold) recommendation on the stock. Keeping that recommendation intact, he made another bump one week later, to $306 per share. According to reports, Brett's second hike was due to upward adjustments to his full-year 2026 and 2027 estimates. Still, the analyst remains cautious, as he feels that the share price gains have left it fairly valued. I wouldn't necessarily agree. AI is a powerful motor of growth for any company involved in its development, and the high demand we're experiencing for the technology is long-term. Not only that, but Teradyne is a trusted diagnostics partner in other segments, so even in the unlikely event that demand softens, the company still has a viable business.Read NextOct 31, 2025 •By Scott LevineWhy Teradyne Stock Is Skyrocketing This WeekOct 29, 2025 •By Lee SamahaHere's Why AI Demand Sent Teradyne Stock Up 20% TodayJul 30, 2025 •By Johnny RiceWhy Teradyne Stock Soared 18.9% TodayJul 25, 2024 •By Motley Fool Markets TeamTeradyne's Q2 2024 Earnings Surpass ExpectationsAug 3, 2023 •By Nicholas RossolilloIs This Cathie Wood Chip Stock a Buy Right Now?Jul 25, 2023 •By Nicholas RossolilloIs This AI and Robotics Chip Stock a Buy Now?About the AuthorEric Volkman is a contributing Motley Fool finance and stock market analyst. Previously, Eric was an equities analyst at European investment bank Raiffeisen Capital and Investment. He’s also been a freelance finance writer since 1995. He studied at Susquehanna University.TMFVolkmanStocks MentionedTeradyneNASDAQ: TER$273.45(-10.51%)-$32.13Morgan StanleyNYSE: MS$160.27(-1.40%)-$2.28*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.